Cargando…

Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control

Mostrar otras versiones (1)

Glycosylated hemoglobin (HbA1c) has been the sole surrogate marker for assessing diabetic complications. However, consistently reported limitations of HbA1c are that it lacks detailed information on short-term glycemic control and can be easily interfered with by various clinical conditions such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Jee Hee, Kim, Jae Hyeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801761/ https://www.ncbi.nlm.nih.gov/pubmed/33389957 http://dx.doi.org/10.4093/dmj.2020.0257

Ejemplares similares

Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
por: Yoo, Jee Hee, et al.
Publicado: (2021)

Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
por: Yoo, Jee Hee, et al.
Publicado: (2023)

The Benefits Of Continuous Glucose Monitoring In Pregnancy
por: Yoo, Jee Hee, et al.
Publicado: (2023)

Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study
por: Cho, So Hyun, et al.
Publicado: (2023)

Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring
por: Yapanis, Michael, et al.
Publicado: (2022)

Circulating osteocalcin is associated with time in range and other metrics assessed by continuous glucose monitoring in type 2 diabetes
por: Liu, Jun, et al.
Publicado: (2022)

The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control
por: Yoshii, Hidenori, et al.
Publicado: (2022)

Flash Continuous Glucose Monitoring in Primary Care Settings: The Need for Measurement of Novel Glycemic Metrics to Adopt Policy and Practice Change
por: Cowart, Kevin
Publicado: (2020)

Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
por: Bae, Ji Cheol, et al.
Publicado: (2022)

Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring
por: Zhou, Jian, et al.
Publicado: (2011)

Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study
por: Calhoun, Peter, et al.
Publicado: (2021)

Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19
por: Gómez, Ana María, et al.
Publicado: (2021)

Discrepancies in glycemic metrics derived from different continuous glucose monitoring systems in adult patients with type 1 diabetes mellitus
por: Zhou, Yongwen, et al.
Publicado: (2022)

Application of the New “Points in Range” Metrics in the Assessment of In-Hospital Glycemic Control
por: Rosinha, Patrícia, et al.
Publicado: (2023)

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data
por: Peyser, Thomas A., et al.
Publicado: (2018)

Continuous Glucose Monitoring in Adolescents With Obesity: Monitoring of Glucose Profiles, Glycemic Excursions, and Adherence to Time Restricted Eating Programs
por: Naguib, Monica N., et al.
Publicado: (2022)

Accuracy of Continuous Glucose Monitoring Measurements in Normo-Glycemic Individuals
por: Akintola, Abimbola A., et al.
Publicado: (2015)

Abstract 129: Continuous glucose monitoring in type 2 diabetes mellitus to assess glycemic control and glycemic variability
Publicado: (2022)

Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: a prospective cohort study
por: Liang, Xinxiu, et al.
Publicado: (2023)

Serum 25-hydroxyvitamin D level is associated with short-term glycemic variability metrics derived from continuous glucose monitoring in T2DM
por: Zhao, Guohong, et al.
Publicado: (2023)

Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus
por: Lee, Da Young, et al.
Publicado: (2023)

Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring
por: Chung, Seung Min, et al.
Publicado: (2021)

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD
por: Presswala, Lubaina, et al.
Publicado: (2019)

Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
por: Yang, Junpeng, et al.
Publicado: (2020)

Continuous Glucose Monitoring for Evaluation of Glycemic Excursions after Gastric Bypass
por: Halperin, Florencia, et al.
Publicado: (2011)

Glycemic fluctuations caused by COVID-19: Results from continuous glucose monitoring
por: Shen, Yun, et al.
Publicado: (2021)

Continuous Glucose Monitoring in Patients Following Simultaneous Pancreas–Kidney Transplantation: Time in Range and Glucose Variability
por: Dmitriev, Ilya V., et al.
Publicado: (2023)

Navigating the Seas of Glycemic Control: The Role of Continuous Glucose Monitoring in Type 1 Diabetes Mellitus
por: Moon, Jun Sung
Publicado: (2023)

Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges
por: Osugi, Keiko, et al.
Publicado: (2023)

Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes
por: Ling, James, et al.
Publicado: (2022)

Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve Gastrectomy
por: Al-Ozairi, Ebaa, et al.
Publicado: (2020)

Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring
por: Zhang, Fan, et al.
Publicado: (2021)

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
por: Battelino, Tadej, et al.
Publicado: (2019)

Exercise Strategies to Optimize Glycemic Control in Type 2 Diabetes: A Continuing Glucose Monitoring Perspective
por: van Dijk, Jan-Willem, et al.
Publicado: (2015)

Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes
por: Guo, Qing-Yu, et al.
Publicado: (2020)

Glycemic variation in uncontrolled Graves’ disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring
por: Gao, Gu, et al.
Publicado: (2018)

Tight glycemic control: comparison of a real-time continuous interstitial tissue glucose monitoring system with arterial plasma glucose measurement in critically ill patients
por: Vlkova, A, et al.
Publicado: (2008)

Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
por: Friedman, Jared G, et al.
Publicado: (2023)

Continuous glucose monitoring reveals glycemic variability and hypoglycemia after vertical sleeve gastrectomy in rats
por: Evers, Simon S., et al.
Publicado: (2019)

Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range
por: van der Linden, Joost, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5l4552vekbqibp88sg4j2gb2og